Galaxy Medicare Stock Price Today (NSE: GML)
Fundamental Score
Galaxy Medicare Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Galaxy Medicare share price today is ₹19.75, up +0.00% on NSE/BSE as of 19 June 2026. Galaxy Medicare (GML) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹28.15 (Cr). The 52-week high for GML share price is ₹23.80 and the 52-week low is ₹16.20. At a P/E ratio of 8.56x, GML is currently trading below its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 14.46% and a debt-to-equity ratio of 0.19.
Galaxy Medicare Share Price Chart — NSE/BSE Historical Performance
Galaxy Medicare share price chart: 2.33% return over the past month. 52-week high ₹23.80, 52-week low ₹16.20.
Galaxy Medicare — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹19.50 | ₹19.75 | ₹19.50 | ₹19.75 | 12.00K (Cr) | |
| ₹18.10 | ₹19.80 | ₹18.10 | ₹19.75 | 10.00K (Cr) | |
| ₹19.80 | ₹19.80 | ₹19.30 | ₹19.30 | 6.00K (Cr) | |
| ₹18.10 | ₹18.10 | ₹18.10 | ₹18.10 | 4.00K (Cr) | |
| ₹20.10 | ₹20.10 | ₹19.75 | ₹19.75 | 16.00K (Cr) | |
| ₹20.00 | ₹20.00 | ₹19.00 | ₹19.95 | 10.00K (Cr) | |
| ₹20.25 | ₹20.25 | ₹19.00 | ₹19.95 | 6.00K (Cr) | |
| ₹19.20 | ₹19.20 | ₹19.20 | ₹19.20 | 2.00K (Cr) | |
| ₹19.65 | ₹19.65 | ₹19.10 | ₹19.30 | 6.00K (Cr) | |
| ₹17.25 | ₹17.25 | ₹17.25 | ₹17.25 | 4.00K (Cr) |
Galaxy Medicare — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹19.50 | ₹19.75 | ₹19.50 | ₹19.75 | +1.28% | |
| ₹20.25 | ₹20.25 | ₹18.10 | ₹19.75 | -2.47% | |
| ₹17.25 | ₹19.65 | ₹17.25 | ₹19.20 | +11.30% | |
| ₹16.90 | ₹18.05 | ₹16.20 | ₹17.30 | +2.37% | |
| ₹18.50 | ₹19.50 | ₹18.40 | ₹18.40 | -0.54% | |
| ₹20.85 | ₹22.40 | ₹17.60 | ₹17.90 | -14.15% | |
| ₹18.55 | ₹23.80 | ₹18.20 | ₹22.00 | +18.60% | |
| ₹22.00 | ₹22.90 | ₹19.75 | ₹19.75 | -10.23% |
AI Research Briefing
Powered by Gemini · 2026-04-13
Micro-cap play on India medical device boom, but liquidity risk and execution challenges make it a gamble.
WHAT'S HAPPENING NOW (last 2-4 weeks)
No major catalysts found after live search. Last news was on April 10, 2026, where 84% increase compared to the previous closing price.
CORE STORY (THE REAL GAME)
Galaxy Medicare is a micro-cap player in the Indian medical equipment and supplies market, attempting to ride the wave of increased healthcare spending and government initiatives to boost domestic manufacturing. The real game is whether they can scale operations and compete with larger players in a fragmented market.
- India medical equipment market growth projected at 8.30% CAGR
- Government initiatives supporting domestic manufacturing
- Low P/E relative to industry
- Significant order wins
- Successful expansion into new markets
- Improved profitability and cash flow generation
- Micro/SME cap = liquidity risk
- Intense competition from larger players
- Inconsistent cash flow
Promoter holding is high at 72.43%, FII holding is 1.85%, DII holding is 0%. No significant change in promoter or FII/DII activity.
Tailwind: Expanding healthcare infrastructure and rising chronic disease prevalence in India.
No - Free Cash Flow 5Y: ₹None Cr
If Galaxy Medicare can execute its growth strategy and improve profitability, the stock could re-rate. However, failure to scale up and compete effectively could lead to significant downside.
Primary Thesis Risk
Liquidity risk and execution challenges could derail growth story.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Galaxy Medicare Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Galaxy Medicare Fundamental Analysis & Valuation Benchmarking
Educational evaluation of GML across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Excellent ROCE Performance (17.72%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Attractive Valuation (P/E: 8.56 vs Industry: 47.87)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Conservative Debt Levels (D/E: 0.19)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (6.97x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (72.43%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
2 factors identified
Limited Institutional Interest (FII+DII: 1.85%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Galaxy Medicare vs Medical Equipment & Supplies Peers
Peer Comparison - Medical Equipment & Supplies
Compare Galaxy Medicare with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
27.9/100 | ₹19.75₹20 | ₹28.15₹28.15 | 8.56Average 8.6 Average | 14.46%Average 14.46% Average | 17.72%Good 17.72% Good | 0.19Excellent 0.2 Excellent | — — | — — | 0.00% | |
Poly Medicure LtdPoly Medicure L... POLYMED • 531768 | 60.7/100 | ₹1330.30₹1330 | ₹19506.20₹19506.20 | 53.89Average 53.9 Average | 15.77%Good 15.77% Good | 20.08%Excellent 20.08% Excellent | 0.08Excellent 0.1 Excellent | 28.38%Excellent 28.38% Excellent | 19.44%Excellent 19.44% Excellent | 0.18% |
Fischer Medical Ventures LtdFischer Medical... FISCHER • 524743 | 31.7/100 | ₹37.46₹37 | ₹3162.93₹3162.93 | 157.52Average 157.5 Average | 0.70%Poor 0.70% Poor | 1.08%Poor 1.08% Poor | 0.08Excellent 0.1 Excellent | — — | — — | 0.01% |
Laxmi Dental LtdLaxmi Dental Lt... LAXMIDENTL • 544339 | 68.7/100 | ₹243.13₹243 | ₹1488.44₹1488.44 | 57.78Average 57.8 Average | 21.88%Excellent 21.88% Excellent | 19.20%Good 19.20% Good | 0.04Excellent 0.0 Excellent | 57.51%Excellent 57.51% Excellent | 9.81%Good 9.81% Good | 0.00% |
OSEL DEVICES LIMITEDOSEL DEVICES LI... OSELDEVICE • | 42.1/100 | ₹496.70₹497 | ₹1363.11₹1363.11 | 50.06Average 50.1 Average | 30.08%Excellent 30.08% Excellent | 31.14%Excellent 31.14% Excellent | 0.56Good 0.6 Good | — — | — — | 0.00% |
Tarsons Products LtdTarsons Product... TARSONS • 543399 | 13.8/100 | ₹214.98₹215 | ₹1224.98₹1224.98 | 59.58Average 59.6 Average | 4.75%Poor 4.75% Poor | 6.91%Poor 6.91% Poor | 0.63Good 0.6 Good | — — | — — | 0.00% |
60.3/100 | ₹173.00₹173 | ₹633.93₹633.93 | 25.77Average 25.8 Average | 36.78%Excellent 36.78% Excellent | 31.12%Excellent 31.12% Excellent | 0.53Good 0.5 Good | 90.06%Excellent 90.06% Excellent | 61.82%Excellent 61.82% Excellent | 0.00% | |
Prevest Denpro LtdPrevest Denpro ... PREVEST • 543363 | 68.5/100 | ₹408.00₹408 | ₹521.17₹521.17 | 26.18Average 26.2 Average | 18.74%Good 18.74% Good | 25.25%Excellent 25.25% Excellent | 0.00Excellent 0.0 Excellent | 29.49%Excellent 29.49% Excellent | 22.80%Excellent 22.80% Excellent | 0.23% |
HSIL LimitedHSIL Limited... HSIL • 543916 | 61.2/100 | ₹413.00₹413 | ₹354.57₹354.57 | 34.23Average 34.2 Average | 13.58%Average 13.58% Average | 16.35%Good 16.35% Good | 0.43Excellent 0.4 Excellent | 74.11%Excellent 74.11% Excellent | 13.69%Good 13.69% Good | 0.00% |
47.7/100 | ₹187.00₹187 | ₹294.37₹294.37 | 32.71Average 32.7 Average | 13.56%Average 13.56% Average | 18.45%Good 18.45% Good | 0.01Excellent 0.0 Excellent | — — | — — | 0.00% | |
Nureca LtdNureca Ltd... NURECA • 543264 | 36/100 | ₹272.15₹272 | ₹292.61₹292.61 | 71.19Average 71.2 Average | -1.12%Poor -1.12% Poor | -0.90%Poor -0.90% Poor | 0.03Excellent 0.0 Excellent | — — | 1.98%Average 1.98% Average | 0.00% |
Top Medical Equipment & Supplies Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Poly Medicure Ltd share price19506.20 Cr
- Fischer Medical Ventures Ltd share price3162.93 Cr
- Laxmi Dental Ltd share price1488.44 Cr
- OSEL DEVICES LIMITED share price1363.11 Cr
- Tarsons Products Ltd share price1224.98 Cr
Galaxy Medicare Quarterly Performance
Latest quarterly metrics for GML — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
N/A
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
N/A
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Galaxy Medicare Technical Indicators
SMA 50, SMA 200, RSI and volume signals for GML — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Galaxy Medicare Financial Statements
Annual income statement, balance sheet and cash flow for Galaxy Medicare (GML) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Galaxy Medicare
About GML (Galaxy Medicare)
Galaxy Medicare (GML) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplies sector with ...a current market capitalisation of ₹28.15 (Cr). Galaxy Medicare has delivered a Return on Equity (ROE) of 14.46% and a ROCE of 17.72%. The debt-to-equity ratio stands at 0.19, reflecting the company's capital structure. Investors tracking GML share price can monitor key metrics including P/E ratio, promoter holding of 72.43%, and quarterly earnings growth.
Company Details
GML Share Price: Frequently Asked Questions
What is the current share price of Galaxy Medicare?
Galaxy Medicare (GML) trades at ₹19.75 on NSE. Market cap ₹28.15 (Cr). Educational data only.
What is the P/E ratio of Galaxy Medicare?
Galaxy Medicare has a P/E of 8.56x vs industry average 47.87x.
What is the Bull Run score for Galaxy Medicare?
Galaxy Medicare has a Bull Run score of 27.9/100 based on 25+ financial parameters.
Does Galaxy Medicare pay dividends?
Galaxy Medicare has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Galaxy Medicare?
Galaxy Medicare has ROE of 14.46%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Galaxy Medicare?
Galaxy Medicare has debt-to-equity of 0.19.
Is Galaxy Medicare a good investment?
Bull Run gives Galaxy Medicare a score of 27.9/100. This is not investment advice — consult a SEBI-registered advisor.